Floatz logo

Carbon Nanoparticle Suspension

Soft Tissue Cancer

Sichuan Enray Pharmaceutical Sciences CompanyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Soft Tissue Cancer cohort.

Asset / SponsorPhaseRating
Carbon Nanoparticle-Loaded Iron
Sichuan Enray Pharmaceutical Sciences Company
Phase 2CCC
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Sichuan Enray Pharmaceutical Sciences Company
Phase 2CCC

Same molecule, other indications

Carbon Nanoparticle Suspension is also rated in:

HNSCCDormant
CCC
Indicative ·
53 / 100
View asset →
SurgeryDormant
D
Indicative ·
30 / 100
View asset →
metastatic malignant neoplasm in the lymph nodesDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →